Evogene (EVGN) Misses Q4 EPS by 20c

Evogene (NASDAQ: EVGN) reported Q4 EPS of ($0.61), $0.20 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $2.28 million versus the consensus estimate of $650 thousand.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank
• Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy